杀粉蝶菌素A1生物合成基因簇中甲基转移酶PieB2的功能

【目的】研究杀粉蝶菌素A1产生菌中甲基转移酶基因pieB2的功能。【方法】利用接合转移和同源重组双交换的方法,构建pieB2基因缺失突变株,以及利用接合转移的方法,构建回补菌株。通过高保真PCR克隆pieB2基因到表达载体pET28a上,构建质粒pJTU5997,转化入大肠杆菌E.coliBL21(DE3)/pLysE中诱导表达。利用高效液相色谱检测PieB2的体外酶活。【结果】获得了pieB2基因缺失的双交换突变株。发酵结果显示,该突变株不再产生杀粉蝶菌素A1,而是积累了一种脱甲基产物。N-末端融合组氨酸标签的PieB2在大肠杆菌中获得可溶性表达,通过体外催化证明了PieB2甲基转移酶的功能。【结论】体内遗传实验和体外生化实验证明了PieB2作为甲基转移酶在杀粉蝶菌素A1合成中的作用。     

链霉菌胞外多糖139A生物合成中引导糖基转移酶基因的克隆和鉴定

链霉菌139能够产生一种新的胞外多糖139A,该多糖具有抗类风湿性关节炎的活性。为研究多糖139A的生物合成基因簇,首要策略是克隆到在多糖139A的生物合成中起关键作用的引导糖基转移酶基因。根据其他几个种属的糖基转移酶氨基酸序列的两个保守区域设计简并引物,通过PCR方法扩增出相应的DNA片段作为探针,从链霉菌139基因组文库中分离到引导糖基转移酶基因ste5,并定位于约32kb的基因簇上。序列分析发现其蛋白序列与引导糖基转移酶具有较高的同源性,其C-端含有A,B和C3个保守区,N-端具有5个跨膜区。引导糖基转移酶基因阻断突变株不能够产生多糖139A表明其参与多糖139A的生物合成。     

次黄嘌呤-鸟嘌呤磷酸核糖转移酶突变体的基因构建、表达和性质

通过对我国嗜热菌Thermoanaerobactertengcongensis中次黄嘌呤 鸟嘌呤磷酸核糖转移酶 (HGPRT)三维结构进行同源模建 ,设计出HGPRT的突变体K1 33A、K1 33S和K1 33T。用抗性筛选法 ,对HGPRT的基因进行了定点突变 ,并实现了在大肠杆菌中的高效表达。野生型HGPRT及其突变体K1 33A、K1 33S和K1 33T的催化动力学研究表明 ,HG PRT突变体改变并扩大了底物专一性 ,具有催化嘌呤类似物的活性。     

蒺藜苜蓿DGAT1基因的克隆和功能鉴定

该研究采用RT-PCR与电子克隆的方法,从蒺藜苜蓿cDNA中克隆得到2个编码二脂酰甘油酰基转移酶(diacylglycerol acyltransferase,DGAT)的基因MtDGAT1-1和MtDGAT1-2。MtDGAT1-1长1 620bp,编码539个氨基酸;MtDGAT1-2长1 524bp,编码507个氨基酸。多序列比对显示,MtDGAT1-1和MtDGAT1-2编码蛋白具有典型的植物DGAT1结构域。表达分析显示,MtDGAT1-1和MtDGAT1-2在根、茎、叶、花、种子中都有表达,在种子发育中高表达,且MtDGAT1-1于种子发育的中前期高表达,而MtDGAT1-2于种子发育的中后期高表达。酵母互补实验证实,MtDGAT1-2编码蛋白具有DGAT酶活性,能够恢复H1246的TAG合成和油体形成;而MtDGAT1-1编码蛋白不能恢复H1246的TAG合成和油体形成。     

水稻中一个谷胱甘肽转移酶基因的克隆、表达和酶活性分析

OsGSTL1是位于水稻3号染色体上的一个λ类谷胱甘肽转移酶基因,由8个内含子和9个外显子组成,编码一个由243个氨基酸组成的多肽链。将OsGSTL1克隆到酵母表达载体pYTV上,转化大肠杆菌,然后再转化酵母菌PEP4。Western印迹分析表明外源OsGSTL1基因在转基因酵母中表达,分析半乳糖诱导表达的酵母粗提液的谷胱甘肽转移酶活性表明:转基因酵母的谷胱甘肽转移酶较非转基因酵母和未诱导的酵母高,说明OsGSTL1在转基因酵母中受半乳糖的诱导表达,具有谷胱甘肽转移酶活性。     

苦荞糖基转移酶基因的克隆及活性鉴定

糖基化修饰在调控各种小分子的溶解度、稳定性及生物活性中具有重要的作用。该研究基于苦荞转录组数据,克隆获得2条糖基转移酶基因（FtUFGT4和FtUFGT5）,并对其在大肠杆菌中的表达产物进行酶催活性鉴定。结果表明：（1）获得的苦荞糖基转移酶基因cDNA分别为1 434和1 470 bp,其编码蛋白同属于拟南芥糖基转移酶E类群,可能参与黄酮类化合物的糖基化。（2）多重序列比对表明,FtUFGT4和FtUFGT5蛋白C端都具有PSPG框,其催化活性位点分别是H17和H16;FtUFGT4和FtUFGT5都是典型的植物糖基转移酶GT B结构,二者的蛋白模型能与矢车菊素和UDP进行分子对接。（3）FtUFGT4和FtUFGT5在大肠杆菌中获得了可溶性表达,薄层层析实验表明二者均具有催化矢车菊素糖基化为矢车菊素 3 O 葡萄糖苷的活性。     

甜叶菊葡糖基转移酶基因UGT76G2的克隆及生物信息学分析

本研究利用RT-PCR方法从甜叶菊(Stevia rebaudian)叶片中分离了与甜叶菊UGT76G1高度同源的UGT76G2基因,该基因编码一条分子量为52.029 kD的由458个氨基酸残基组成的多肽,含有c-端所特有的高度保守的信号序列PSPG基序和N-端膜结合序列,属于植物中特有PSPG基序的UGT家族成员.半定量RT-PCR分析表明:UGT76G2在甜叶菊根、茎、叶、花不同组织中具有组织表达特异性,在叶组织中的表达丰度略高,在根中不表达而在茎中表达较低.推断的UGT76G2编码产物与其它参与植物次级代谢产物的糖基转移相关酶同源比对和系统发生分析表明该蛋白与康乃馨(Dianthus caryophyllus)DicGT4、棉花(Gossypi-um hirsutum)GhUGT1、甜叶菊(Stevia rebaudian)UGT76H1及玉米(Zea mays)BX8的一致性较高,分别为41%、35%、35%和32%.对UGT76G2和UGT76G1的次级结构和立体结构分析发现,苜蓿(Medicago sativa)UGT71G1与二者的一致性皆为23%,它们有类似的次级结构.在C-端的PSPG信号区内具有10个相同的基质结合位点.但在UGT76G2和UGT76G1之间也有个别位置氨基酸存在差异.它们的N-端含有保守的组氨酸H25和天冬氨酸D124残基,可能与受体的结合有关.     

一个新的产黄青霉谷胱甘肽转移酶基因的克隆和鉴定

以产黄青霉(Penicillium chrysogenum Thom)cDNA为模板,克隆得到一个新的谷胱甘肽转移酶基因PcgstB,其开放阅读框长651bp,编码216个氨基酸的蛋白质。与已知序列进行BLASTp比较显示,该蛋白具有保守的GST结构域,与烟曲霉GstB的序列一致性最高,达65%。将PcgstB与原核表达载体pTrc99A连接得到表达质粒pTrc-gstB,转化大肠杆菌DH5α,经IPTG诱导后获得以可溶形式表达的重组PcGstB蛋白。以1-chloro-2,4-dinitrobenzene(CDNB)为底物检测,确认该蛋白具有GST活性。     

大肠杆菌丝氨酸羟甲基转移酶基因(glyA)的克隆和表达

利用插入失活及营养缺陷型互补法将大肠杆菌K12 13kb的glyA基因克隆到质粒pBR329中。将重组质粒酶切,亚克隆,确定2.6kb PstI-EcoRI亚克隆片段带有完整的glyA基因。共获得12株glyA基因重组菌,对重组质粒进行了酶切鉴定。不同重组菌丝氨酸羟甲基转移酶(SHMT)活性及其酶表达量均不相同。受体菌未检测到丝氨酸的产生。重组菌株JM109(pSM13)、K12(pSM13)、K12(pSM14)和K12(pSM15)SHMT酶表达量分别占全菌可溶性蛋白的15.7％、15.4％、11.8％和9.48％。     

金花茶类黄酮糖基转移酶基因的克隆和功能初步研究

类黄酮糖基转移酶(UDP flavonoid glycosyltransferase, UFGT)催化黄酮醇、花青素等形成稳定的糖苷,是黄酮醇苷、花青素苷合成的最后一步反应的关键。该研究以金花茶的花瓣为材料,采用PCR扩增的方法,获得了2个金花茶转录组中筛选到的类黄酮糖基转移酶基因。结果显示：(1)CnUFGT14基因(登录号为MT370521)全长1 562 bp,开放阅读框1 380 bp,编码459个氨基酸;CnUFGT15基因(登录号为MT370520)全长1 546 bp,开放阅读框1 368 bp,编码455个氨基酸;两个蛋白序列均具有UFGT蛋白特有的 PSPG 保守区域。(2)系统进化树分析发现,CnUFGT14和CnUFGT15分别与茶树UFGT78A14和UFGT78A15亲缘关系最近。(3) 荧光定量PCR分析发现,CnUFGT14基因的表达量与多种多酚组分的含量呈正相关,CnUFGT15基因的表达量与花瓣黄酮醇、多酚等的含量相关性不显著。(4)亚细胞定位研究发现,CnUFGT14、CnUFGT15蛋白在细胞核膜、细胞质、细胞膜部位均呈现明显的定位。(5)叶盘法转化烟草发现,CnUFGT14基因表达量较高的转基因株系中总多酚含量及多种多酚组分含量升高,而CnUFGT15基因的转基因株系中黄酮、多酚组分变化不显著。研究表明,CnUFGT14基因具有促进多酚合成的作用,而CnUFGT15基因对类黄酮通路不具有明显作用。     

喷司他丁的合成及其生物合成机制研究进展

喷司他丁是一种核苷类抗生素,对腺苷脱氨酶有极强的抑制效果,在临床治疗恶性肿瘤方面具有广泛应用.但其生产成本高、市售价格昂贵,难以满足需求.近10年来,关于生物合成喷司他丁的研究主要集中在菌种选育、优化培养基组分与发酵工艺等方面.目前,尽管喷司他丁的生物合成机制得到了阐明,但生物合成喷司他丁方面的综述尚无.对此,文中综述...     

Cloning, expression and characterization of gene sgcD involved in the biosynthesis of novel antitumor lidamycin

Lidamycin, an antitumor antibiotic composed of a macro-molecule peptide and enediyne chromophore[1] and originally named C1027, is produced by Streptomyces globisporus C1027 isolated from the soil in Qianjiang County, Hubei Province, China. It has extremely high antitu- mor activity, which has been proved to be the highest among antitumor compounds[2], being 1000- fold higher than that of adriamycin commonly used in clinic. The structure of lidamycin consists of an acid apoprotein and a chr…     

Cloning, expression and characterization of gene sgcD involved in the biosynthesis of novel antitumor lidamycin

Lidamycin with high antitumor activity is a novel enediyne antitumor antibiotic produced by Streptomyces globisporus C1027. The 75 kb biosynthesis gene cluster of lidamycin containing 33 open reading frames has been cloned from S. globisporus C1027. In this paper, the function of sgcD (ORF24) is investigated. Gene disruption experiment proved that sgcD is involved in lidamycin biosynthesis. With homologous comparing analysis, we deduce that sgcD codes aminomutase catalyzing a-tyrosine to β-tyrosine which is one motif for lidamycin. To identify the function of enzyme coded by sgcD, sgcD is cloned into vector pET30a for inducing expression and the activity of expression product is analyzed. The result showed that the expression product of sgcD has the activity of aminomutase. Aminomutase coded by sgcD is the first characterized enzyme involved in the biosynthesis of enediyne antitumor antibiotics. Our research will be helpful to clarifying the biosynthesis mechanism of such kind of antibiotic and to producing new antitumor compounds.     

An unusual UMP C-5 methylase in nucleoside antibiotic polyoxin biosynthesis

Polyoxin is a group of structurally-related peptidyl nucleoside antibiotics bearing C-5 modifications on the nucleoside skeleton. Although the structural diversity and bioactivity preference of polyoxin are, to some extent, affected by such modifications, the biosynthetic logic for their occurence remains obscure. Here we report the identification of PolB in polyoxin pathway as an unusual UMP C-5 methylase with thymidylate synthase activity which is responsible for the C-5 methylation of the nucleoside skeleton. To probe its molecular mechanism, we determined the crystal structures of PolB alone and in complexes with 5-Br UMP and 5-Br dUMP at 2.15 Å, 1.76 Å and 2.28 Å resolutions, respectively. Loop 1 (residues 117–131), Loop 2 (residues 192–201) and the substrate recognition peptide (residues 94–102) of PolB exhibit considerable conformational flexibility and adopt distinct structures upon binding to different substrate analogs. Consistent with the structural findings, a PolB homolog that harbors an identical function from Streptomyces viridochromogenes DSM 40736 was identified. The discovery of UMP C5-methylase opens the way to rational pathway engineering for polyoxin component optimization, and will also enrich the toolbox for natural nucleotide chemistry.     

Cloning and characterization of genes encoded in dTDP-D-mycaminose biosynthetic pathway from a midecamycin-producing strain, Streptomyces mycarofaciens

Two subclusters from Streptomyces mycarofaciens,a midecamycin producer,were clonedand partially sequenced.One region was located at the 5' end of the mid polyketide synthase(PKS)genesand contained the genes midA,midB and midC.The other region was at the 3' end of the PKS genes andcontained midK,midI and midH.Analysis of the nucleotide sequence revealed that these genes encodedTDP-glucose synthase(midA),dTDP-glucose dehydratase(midB),aminotransferase(midC),methyltransferase(midK),glycosyltransferase(midI)and an assistant gene(midH).All of these genes areinvolved in the biosynthesis of dTDP-D-mycaminose,the first deoxysugar of midecamycin,and intransferring the mycaminose to the midecamycin aglycone in S.mycarofaciens.Similar to gene pairsdes Ⅷ/desⅦ in S.venezuelae and tylMⅢ/tylMⅡ in S.fradiae,the product of midH probablyfunctions as an auxiliary protein required by the MidI protein for efficient glycosyltransfer in midecamycinbiosynthesis.     

Cloning and characterization of a potato StAN11 gene involved in anthocyanin biosynthesis regulation

Anthocyanins are a class of products of plant secondary metabolism and are responsible for tubers color in potato.The biosynthesis of anthocyanins is a complex Researchbiological process,in which multiple genes are involved including structural genes and regulatory genes.In this study,StAN11,a WD40-repeat gene,was cloned from potato cultivar Chieftain(Solanum tuberosum L.).StAN11(HQ599506)contained no intron and its open reading frame(ORF)was 1,029 bp long,encoding a putative protein of 342 amino acids.In order to verify its role in anthocyanin biosynthesis,StAN11 was inserted behind the CaMV-35S promoter of pCMBIA1304 and the recombination vector was introduced into the potato cultivar Désirée plants by Agrobacterium-mediated transformation.The color of transgenic tuber skin was significantly deepened,compared to the wild-type control,which was highly consistent with the accumulation of anthocyanin and expression of StAN11 in transgenic lines tuber skin.Further analysis on the expression of Flavonone-3-hydroxylase(F3H),Dihydroflavonol reductase(DFR),Anthocyanidin synthase(ANS),and Flavonoid 3-O-glucosyl transferase(3GT)in transgenic plants revealed that only DFR was upregulated.This result suggested that StAN11 regulated anthocyanin biosynthesis in potato by controlling DFR expression and accumulation of anthocyanin could be increased through overexpression of StAN11 in the tubers with the genetic background of anthocyanin biosynthesis.     

Cloning and characterization of a gene from Pasteurella haemolytica A1 involved in lipopolysaccharide biosynthesis

Abstract A Pasteurella haemolytica A1 gene involved in the biosynthesis of a moiety on the core of the lipopolysaccharide molecule has been cloned and characterized. Escherichia coli clones which carry this gene showed an alteration of its lipopolysaccharide migration profile on tricine SDS-PAGE and exhibited resistance to the core-specific phage U3. In addition, lipopolysaccharide extracted from the E. coli clones was recognized by an anti-corespecific antiserum, but not by antiserum specific for the O antigen of P. haemolytica A1 lipopolysaccharide. Nucleotide sequence analysis of the cloned DNA identified an open reading frame ( lpsA ) coding for a protein of 263 amino acids which showed significant homology with a Haemophilus influenzae type b lipooligosaccharide biosynthesis gene. PCR amplification of genomic DNA, using primers based on the P. haemolytica A1 lpsA sequence, yielded products from only the A biotypes of P. haemolytica .     

Cloning,expression and characterization of gene <Emphasis Type="Italic">sgcD</Emphasis> involved in the biosynthesis of novel antitumor lidamycin

Lidamycin with high antitumor activity is a novel enediyne antitumor antibiotic producedby Streptomyces globisporus C1027. The 75 kb biosynthesis gene cluster of lidamycin containing 33 open reading frames has been cloned from S. globisporus C1027. In this paper,the function ofsgcD (ORF24) is investigated. Gene disruption experiment proved that sgcD is involved in lidamy-cin biosynthesis. With homologous comparing analysis, we deduce that sgcD codes aminomutasecatalyzing α-tyrosine to β-tyrosine which is one motif for lidamycin. To identify the function of en-zyme coded by sgcD, sgcD is cloned into vector pET30a for inducing expression and the activity ofexpression product is analyzed. The result showed that the expression product ofsgcD has theactivity of aminomutase. Aminomutase coded by sgcD is the first characterized enzyme involved inthe biosynthesis of enediyne antitumor antibiotics. Our research will be helpfulto clarifying thebiosynthesis mechanism of such kind of antibiotic and to producing new antitumorcompounds.     

Cloning and analysis of DNA sequences from Streptomyces hygroscopicus encoding geldanamycin biosynthesis

A gene library constructed from large (20 kb) fragments of total DNA from the geldananmycin-producing strain Streptomyces hygroscopicus 3602 cloned in the plasmid vector pIJ61 were used to transform S. lividans TK24. Three transformants of about 800 tested were found to have acquired the ability to produce an antibiotic lethal to a geldanamycin-sensitive strain of Bacillus subtilis. The plasmids isolated from these transformants, pIA101, pIA102 and pIA103, each contained an insert of 15 kb. A 4.5 kb DNA fragment from the insert in pIA102 hybridised to DNA from S. hygroscopicus 3602 and to DNA encoding part of the erythromycin polyketide synthase but not to S. lividans TK24 DNA. The integration-defective phage vector C31 KC515 containing this 4.5 kb fragment was able to lysogenise S. hygroscopicus 3602 to produce lysogens defective in geldanamycin production. Loss of the prophage restored the ability to produce geldanamycin. Extracts of fermentation broth cultures of S. lividans containing pIA101, pIA102 and pIA102 and pIA103 analysed by thin-layer chromatography (TLC) contained compounds identical or very similar to purified geldanamycin, which were not present in S. lividans. These compounds showed a mass spectrum indistinguishable from geldanamycin. The evidence suggests that the clones contain DNA sequences encoding functions required for geldanamycin biosynthesis including components of the polyketide synthase.     

Cloning, heterologous expression, and characterization of a phenylalanine aminomutase involved in Taxol biosynthesis

Biosynthesis of the N-benzoyl phenylisoserinoyl side chain of the anticancer drug Taxol starts with the conversion of 2S-alpha-phenylalanine to 3R-beta-phenylalanine by phenylalanine aminomutase (PAM). A gene cloning approach was based on the assumption that PAM would resemble the well known plant enzyme phenylalanine ammonia lyase. A phenylalanine ammonia lyase-like sequence acquired from a Taxus cuspidata cDNA library was expressed functionally in Escherichia coli and confirmed as the target aminomutase that is virtually identical to the recombinant enzyme and clone from Taxus chinensis, acquired recently by a reverse genetics approach (Bristol-Myers Squibb (August 14, 2003) U. S. Patent WO 03/066871 A2). The full-length cDNA has an open reading frame of 2094 base pairs and encodes a protein of 698 residues with a calculated molecular mass of 76,530 Da. The recombinant mutase has a pH optimum of 8.5, a k(cat) value of 0.015 s(-1), and a K(m) of 45 +/- 8 microm for 2S-alpha-phenylalanine. The stereochemical mechanism of PAM involves the removal and interchange of the pro-3S hydrogen and the amino group, which rebonds at C-3 with retention of configuration. The recombinant enzyme appears to catalyze both the forward and reverse reactions with specificity for both 2S-alpha-phenylalanine and 3S- or 3R-beta-phenylalanine substrates, respectively, whereas the related phenylpropanoids 2S-aminocyclohexanepropanoic acid, 2R-alpha-phenylalanine, and 2S-alpha-tyrosine are not converted to their beta-isomers by the mutase.